Independent peer-reviewed research published in Frontiers in Veterinary Science reports strong assay performance in a proof-of-concept evaluation using bovine nasopharyngeal swab samples
CARLSBAD, Calif., June 23, 2026 /PRNewswire/ -- Pictor Holdings Inc., a global targeted proteomic platform company, today highlighted the publication of an independent peer-reviewed study conducted by researchers at Texas A&M University and published in Frontiers in Veterinary Science evaluating the Pictor PictVet® assay for monitoring anti-Mycoplasma bovis (M. bovis) IgG antibodies in bovine nasopharyngeal swabs. The study, titled "Detection of anti-Mycoplasma bovis IgG in bovine nasopharyngeal swabs," was published June 11, 2026, in Frontiers in Veterinary Science (doi: 10.3389/fvets.2026.1856081).